Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T4UE
|
||||
Former ID |
DNC009571
|
||||
Drug Name |
Mycophenolic bis(sulfonamide)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529565] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H18N2O8S2
|
||||
Canonical SMILES |
CC1=C(C(=C(C2=C1COC2=O)O)CCNS(=O)(=O)CS(=O)(=O)N)OC
|
||||
InChI |
1S/C13H18N2O8S2/c1-7-9-5-23-13(17)10(9)11(16)8(12(7)22-2)3-4-15-25(20,21)6-24(14,18)19/h15-16H,3-6H2,1-2H3,(H2,14,18,19)
|
||||
InChIKey |
IVAOVFUEHDFBPQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Inosine-5'-monophosphate dehydrogenase 2 | Target Info | Inhibitor | [529565] | |
Inosine-5'-monophosphate dehydrogenase 1 | Target Info | Inhibitor | [529565] | ||
BioCyc Pathway | Purine nucleotides degradation | ||||
Urate biosynthesis/inosine 5'-phosphate degradation | |||||
Guanosine nucleotides de novo biosynthesis | |||||
Superpathway of purine nucleotide salvage | |||||
Purine nucleotides de novo biosynthesis | |||||
Guanosine ribonucleotides de novo biosynthesisPWY-6353:Purine nucleotides degradation | |||||
Guanosine ribonucleotides de novo biosynthesis | |||||
PANTHER Pathway | De novo purine biosynthesis | ||||
PathWhiz Pathway | Purine Metabolism | ||||
WikiPathways | Nucleotide Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.